Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
HealthTree Resources
Posted by 
Last updated and reviewed on: December 10, 2025We invite you to read the sources below to learn more about CAR T-cell therapy for lymphoma.
News articles and pages
- FDA Determines CAR-T Can Be Safely Given Without Risk Evaluation and Mitigation Strategies (REMS)
- New Way to Engineer CAR T-Cells Could Make it More Accessible
- Is CAR T-cell Therapy More Effective for Transformed Follicular Lymphoma or De Novo DLBCL?
- Can Mental Health Conditions Impact CAR T-Cell Therapy for LBCL Patients?
- CAR-T therapy and secondary hematological malignancies
- Is Odronextamab Effective if CAR-T Stops Working for DLBCL?
- Real World Outcomes of Liso-cel for Large B-cell Lymphoma
- How Effective is Tab-cel for EBV+ Post-Transplant Lymphoma?
- New CAR-T Therapy Targets CD22 to Treat Follicular and Mantle Cell Lymphoma
- How Does Axi-cel Perform in the Real World for People with LBCL?
- If CAR T-Cell Therapy Fails, How Effective Are Bispecific Antibodies for Large B-Cell Lymphoma?
- Studying the Keto Diet's Impact on CAR T-Cells for Large B-Cell Lymphoma
- Understanding How CAR T Works in the Real World for Follicular Lymphoma
- Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients
- CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024
- Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy
- Factors That Can Influence How Well CAR T-Cell Therapy Works for MCL
- Azer-cel, a New CAR T-Cell Therapy for DLBCL
- Is it Safe for R/R DLBCL Patients to Receive CAR T-cell Therapy in an Outpatient Setting?
- How One DLBCL Therapy Is Proving Its Worth: Three Years Later
- New Clinical Trial with Armored CAR T-cells
- Making CAR-T Therapy Safer and More Accessible for DLBCL Patients
- What If My CAR-T Fails?
- EHA 2024: Can Patients Over 75 Be Treated with CAR T-cell Therapy?
- New CAR T-Cell Therapy Approved for MCL
- CAR T-Cell Therapy Advances in Large B Cell Lymphoma
- Liso-cel CAR T-Cell Therapy Receives FDA Approval for Follicular Lymphoma
- Factors that Influence Blood Transfusion Needs for DLBCL Patients Receiving CAR T-Cell Therapy
- CAR T-cell Therapy for Follicular Lymphoma
- A Deep Dive into CAR T-Cell vs. Bispecific Antibodies for Relapsed or Refractory DLBCL
- Predicting Drug Toxicity in CAR T-Cell Therapy Recipients
- Trial of an Education Video to Help CAR-T Cell Therapy Recipients
- MSKCC’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants
- What is CAR T-Cell Therapy?
- HealthTree Celebrates the Accomplishments of Carl June, Father of CAR-T
HealthTree University (HTU) videos
Events recordings
- The Future of Lymphoma Treatment: What's in the Research Pipeline?
- Early-Stage Research: Exploring the Science Behind a Keto Diet and CAR T Therapy in Lymphoma
- From First-Line to Third and Beyond: What to Expect for LBCL Treatments
- Changing Course: Treatment Options for Lymphoma Relapse Following CAR-T Therapy
- CAR-T Therapy for Lymphoma: Barriers and Solutions to Access
- TRANSCEND FL Trial Updates with Dr. Manali Kamdar
- Latest Advancements in CAR T-cell Therapy with Dr. Ehsan Malek
- CAR T-cell Therapy and Stem cell transplant in Lymphoma patients: Current treatment landscape
- From Trial to Triumph: Robyn's Pioneering CAR T-cell Therapy Journey
- CAR T-Cell Therapy Advances in Large B-Cell Lymphoma
- Treatment Options for Relapsed/Refractory DLBCL with Dr. Elif Yilmaz